Sign in

You're signed outSign in or to get full access.

CH

CLS Holdings USA, Inc. (CLSH)·Q3 2023 Earnings Summary

Executive Summary

  • Net revenue of $5.437M declined 2.7% year over year and 10.5% sequentially versus Q2, with record gross margin of 55.5% despite industry-wide pricing pressure; EBITDA rose 401% YoY to $0.505M .
  • Retail (Oasis Cannabis) revenue grew 6% YoY to $3.529M as customer visits rose, while Production (City Trees) fell 15% YoY to $1.908M on wholesale price compression; traffic and market share gains partially offset pricing headwinds .
  • Management highlighted cost discipline—SG&A down $0.632M (-18%), legal fees trending toward $40K/month from ~$125K, and a plan to reduce debt by ~$150K/month through CY2023; an $843,255 ERC payment was anticipated in May/June 2023 .
  • No Wall Street consensus estimates or formal earnings call transcript were available; narrative catalysts centered on margin resilience, retail traffic strength, and cost/debt reduction progress, alongside development of a consumption lounge .

What Went Well and What Went Wrong

What Went Well

  • Record quarterly gross margin: “Our gross margin for the same period was 55.5% versus 51.7%. This was the best quarterly margin the company has ever achieved.”
  • Retail traffic and revenue strength amid industry softness: “Our Oasis Cannabis dispensary saw an increase in visitors of 11,843, an increase of 18%... Seeing a meaningful increase in customers and revenue in an environment where prices are down 30 to 40% is a meaningful accomplishment.”
  • EBITDA surge on cost control: EBITDA increased by $404K to $505K (+401% YoY) as SG&A fell $631,777 (-18%) and COGS declined 10.5% .

What Went Wrong

  • Wholesale pricing pressure and revenue decline: City Trees revenue fell $346,996 (-15%) amid a ~20% average wholesale price decline and an 11% drop in total market revenue .
  • Average ticket down 10% to $45.19, reflecting consumer price sensitivity and competitive dynamics; industry revenue down ~20% in the period .
  • Sequential revenue decline vs Q2 2023 (from $6.074M to $5.437M), driven by macro headwinds (weather, inflation, stimulus fade) and wholesale price compression .

Financial Results

Consolidated metrics vs prior periods

MetricQ3 2022Q2 2023Q3 2023
Revenue ($USD Millions)$5.588 $6.074 $5.437
Gross Margin (%)51.7% n/a55.5%
Net Income (Loss) ($USD Millions)$(0.997) n/a$(1.030)
EBITDA ($USD Millions)$0.101 n/a$0.505
Diluted EPS - Continuing Operations ($USD)n/an/an/a

Notes: EPS not disclosed in filings for these periods .

Segment revenue breakdown

SegmentQ3 2022 ($USD Millions)Q2 2023 ($USD Millions)Q3 2023 ($USD Millions)
Dispensary (Retail)$3.333 $3.793 $3.529
Production (Wholesale)$2.255 $2.281 $1.908
Dispensary % of Total60% 63% 65%
Production % of Total40% 37% 35%

KPIs

KPIQ3 2022Q2 2023Q3 2023
Average ticket ($)$50.20 n/a$45.19
Oasis customer transactions (units)n/a83,744 n/a
Oasis visitors change (units)n/an/a+11,843
City Trees market share changen/an/a+3.8 pts
Industry pricing change (wholesale)n/an/a~-20%

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Operating expense reductionsFY 2023Target to reduce OpEx by $2M “I’m pleased to say that we are achieving this objective.” Maintained
Legal fees run-rateCY 2023~$125K/month (prior run-rate) Trending to ~$40K/month target Lowered
Debt reduction planCY 2023~$10M outstanding as of period Reduce debt by ~$150K/month for balance of CY 2023 New/Specified cadence
ERC inflowMay–Jun 2023n/aAnticipated $843,255 IRS ERC payment New
Capital markets accessNear termn/a“Don’t currently have any meaningful plans to access the debt or equity markets.” Implied maintained conservatism
Consumption loungeLicensing/applicationProspective license granted Nov 30, 2022 Submitted suitability documentation to CCB; project “continues to proceed” Progressing

Earnings Call Themes & Trends

Note: No formal earnings call transcript found; management provided a video and press release update. Trends compiled from Q2 and Q3 filings.

TopicPrevious Mentions (Q1 2023)Previous Mentions (Q2 2023)Current Period (Q3 2023)Trend
Regulatory/legal (consumption lounge)Reverse split and debenture amendments; capital structure updates Prospective lounge license granted; building concept Submitted suitability docs to CCB; project proceeding Advancing toward licensing
Macro/market pricingn/aMarket share gains, competitive pricing Industry revenue down ~20%; wholesale prices -20% Pricing pressure persists
Retail performancen/aSales/day up; transactions +29.06% YoY Visitors +11,843 (+18%); average ticket -10% Strong traffic, lower ticket
Wholesale/product performancen/aTHC distillate near $1M; 10 new dispensaries City Trees shipments up; market share +3.8 pts despite price declines Share gains amid pricing pressure
Cost managementDebenture terms amended; reverse split Cost savings initiatives underway SG&A -18%; legal fees trending to $40K/mo; OpEx reduction goal being achieved Improving cost structure
Capital/debtDebenture amendments, maturities 2023/2024 n/aDebt reduced from ~$23.5M to ~$10M; plan to reduce ~$150K/month Deleveraging

Management Commentary

  • “Our gross margin…was 55.5% versus 51.7%. This was the best quarterly margin the company has ever achieved.”
  • “Our Oasis Cannabis dispensary saw an increase in visitors of 11,843, an increase of 18%... Seeing a meaningful increase in customers and revenue in an environment where prices are down 30 to 40% is a meaningful accomplishment.”
  • “At our manufacturing and wholesale division… we witnessed an 11% drop in total market revenue, along with a 20% average wholesale price decline. However… City Trees saw a market share gain of 3.8%.”
  • “Since taking over as CEO… we have reduced our overall debt from $23.5 million to $10 million… optimistic that we will continue to reduce debt by $150k a month for the balance of CY 2023.”
  • “We… submitted documents to the [Nevada] CCB for the… retail-attached cannabis consumption lounge license.”
  • “We are also anticipating an $843,255 employee retention tax credit payment in May or June of this year.”

Q&A Highlights

  • No formal Q3 2023 earnings call transcript was available in filings; the company furnished a video presentation and press release with prepared remarks and operational detail .
  • Guidance clarifications embedded in prepared remarks covered cost reductions, debt trajectory, ERC timing, and consumption lounge process, rather than a live Q&A .

Estimates Context

  • Wall Street consensus (S&P Global) for Q3 2023 EPS and revenue was unavailable due to missing CIQ mapping/coverage for CLSH. Values could not be retrieved; therefore, estimate comparisons are not provided [GetEstimates error].
  • Given the lack of consensus coverage, investors should anchor to disclosed actuals and management commentary in filings for near-term modeling .

Key Takeaways for Investors

  • Margin resilience is the standout: record 55.5% GM despite pricing pressure suggests effective procurement, production efficiencies, and disciplined pricing/discounting at retail .
  • Retail traffic strength offsets ticket compression: increased visits (+18%) and stable revenue at Oasis underpin defensibility of the in-store experience and value positioning .
  • Wholesale exposure remains the swing factor: City Trees’ share gains are encouraging, but pricing declines drove revenue down; watch wholesale price normalization and unit growth sustainability .
  • Opex and legal cost reductions are material to EBITDA leverage; the SG&A downshift and legal fee trajectory support multi-quarter margin durability .
  • Deleveraging plan and ERC inflow provide near-term liquidity support; continued $150K/month debt reduction could lower interest burden and risk profile through 2023 .
  • Consumption lounge license progress is a potential 2023–2024 top-line catalyst adjacent to the retail footprint; monitor regulatory milestones and capex requirements .
  • With no consensus estimates or call transcript, trading likely reacts to tangible operational metrics: retail traffic trends, wholesale price stabilization, cost controls, and regulatory milestones .

Citations:

  • Q3 2023 8-K and press release (Results of Operations, Exhibit 10.1, and summary tables) .
  • Q2 2023 Shareholder Announcement 8-K (January 17, 2023) .
  • Q1 2023 8-K (capital structure and reverse split context) .

Estimates disclaimer: Wall Street consensus values could not be retrieved; S&P Global data unavailable due to missing CIQ mapping.